Skip to main content
RYANRyan Specialty Holdings, Inc.Sell6.0·$35.28+2.23%
RYAN · Concentration risk · 10-K extracted

Ryan Specialty Holdings (RYAN) concentration risks

Updated

The most significant concentration Ryan Specialty Holdings discloses is E&S market at 78%, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Source: Ryan Specialty Holdings’s SEC Form 10-K filed view the filing on SEC EDGAR ↗

At a glance

Disclosed-size breakdown · 3 disclosed concentrations

HIGH1
MEDIUM1
LOW1
Disclosed concentrations

Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).

HIGHBuilt-inProduct / Revenue mix
78%

E&S market

10-K Item 1: 'For the year ended December 31, 2025, 78% of the total premiums we placed were in the E&S market.'
SEC 10-K · filed Feb 2026
MEDIUMOutside partyCustomer
25.2%

top 5 retail brokers

10-K Item 1A: 'The top five retail brokers with which we place business represented 25.2% and 26.9% of our revenues for the years ended December 31, 2025 and 2024, respectively.'
SEC 10-K · filed Feb 2026
LOWOutside partyCounterparty
20.6%

top 5 insurance carriers

10-K Item 1A: 'The top five insurance carriers (excluding all Lloyd's syndicates combined) for which we place business represented an aggregate of 20.6% and 20.9% of our revenues'
SEC 10-K · filed Feb 2026
TrendMatrix Research · concentration synthesis

What these concentrations mean together

updated 2026-06-24

The company's concentration profile is anchored by a high-share product orientation toward the excess and surplus lines market, with moderate customer and carrier concentrations layered underneath. For the year ended December 31, 2025, 78% of total premiums placed were in the E&S market — a high share by disclosed size and structural in character, reflecting a deliberate positioning in the specialty insurance segment where standard admitted carriers typically do not compete. This concentration is a defining feature of the business model rather than an idiosyncratic dependency, and its direction is stable given the intentional focus on non-standard and complex risks. At the distribution level, the top five retail brokers with which business is placed represented 25.2% of revenues for the year ended December 31, 2025 — a medium-share, dependency-type exposure. While the company is a wholesale intermediary, it relies on retail brokers to generate submissions, meaning the volume of business flowing through the top five relationships matters for revenue. At the carrier level, the top five insurance carriers (excluding all Lloyd's syndicates combined) represented 20.6% of revenues — a low-share dependency, indicating the carrier panel is reasonably diversified and no single underwriter absorbs a dominant share of placed business. Together the profile is coherent: a high-share E&S specialty orientation sits atop a moderate broker concentration and a relatively diffuse carrier panel. The dominant risk is that market conditions shift the relative attractiveness of E&S versus admitted insurance, compressing the addressable volume for the company's specialty focus.

For the engine’s reasoning on RYAN’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Industry peers · Insurance - Specialty

Peer concentration profile

SymbolNameHIGHMEDIUMLOWTotal
RYANRyan Specialty Holdings, Inc.1113
ESNTEssent Group Ltd.1012
AXSAxis Capital Holdings Limited0145
ACTEnact Holdings, Inc.0112
AGOAssured Guaranty Ltd.0000
FAFFirst American Corporation (New0000

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.

Concentration disclosures are extracted verbatim from SEC 10-K filings; the disclosed-size classification and the synthesis above are engine-derived. Size reflects how large each exposure is against fixed share thresholds (HIGH >50%, MEDIUM 25–50%, LOW <25% or an explicit diversification statement), not a judgment of how dangerous it is, and is not a buy/sell rating, a price target, or a view on the stock. Not a complete list of risk factors — see the full filing.

Home Stocks RYAN Concentration risk